Литература

Поставить закладку

Депрессия и риск развития соматических заболеваний: руководство для врачей / под ред. Н. Г. Незнанова, Г. Э. Мазо, А. О. Кибитова. М., 2018. 248 с.
Павловский А. В., Моисеенко В. Е., Попов С. А. и соавт. Аффективные нарушения как предиктор риска развития онкологических заболеваний на примере злокачественных опухолей поджелудочной железы // Медицинский алфавит. 2020; 29: 44–47.
Рукавишников Г. В., Мазо Г. Э. Шизофрения и онкологические заболевания: в поисках решения «эпидемиологической головоломки» // Социальная и клиническая психиатрия. 2019; 29 (4): 84–89.
Рукавишников Г. В., Незнанов Н. Г., Мартынов А. И., Мазо Г. Э. Терапия депрессии у пациентов с коморбидными соматическими заболеваниями // Терапия. 2020; 6 (3): 76–83.
Breitbart W., Rosenfeld B., Tobias K. et al. Depression, cytokines, and pancreatic cancer // Psychooncology. 2014; 23 (3): 339–345.
Botwinick I. C., Pursell L., Yu G. et al. A biological basis for depression in pancreatic cancer // HPB (Oxford). 2014; 16: 740–743.
Butow P. N., Hiller J. E., Price M. A. et al. Epidemiological evidence for a relationship between life events, coping style, and personality factors in the development of breast cancer // J. Psychosom. Res. 2000; 49: 169–181.
Chan C., Lin H. J., Lin J. Stress-associated hormone, norepinephrine, increases proliferation and IL-6 levels of human pancreatic duct epithelial cells and can be inhibited by the dietary agent, sulforaphane // Int. J. Oncol. 2008; 33: 415–419.
Chida Y., Hamer M., Wardle J. et al. Do stress-related psychosocial factors contribute to cancer incidence and survival? // Nat. Clin. Pract. Oncol. 2008; 5: 466–475.
Dalton S. O., Boesen E. H., Ross L. et al. Mind and cancer: do psychological factors cause cancer? // Eur. J. Cancer. 2002; 38: 1313–1323.
Depression and Cancer / ed. by D. W. Kissane, M. Maj, N. Sartorius. Oxford, 2011. 258 p.
Desmarais J. E., Looper K. J. Interactions between tamoxifen and antidepressants via cytochrome P450 2D6 // J. Clin. Psychiatry. 2009; 70 (12): 1688–97.
Ferlay J., Soerjomataram I., Dikshit R. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 // Int. J. Cancer. 2015; 136 (5): E359–E386.
Fox C. M., Harper A. P., Hyner G. C. et al. Loneliness, emotional repression, marital quality, and major life events in women who develop breast cancer // J. Community Health. 1994; 19: 467–482.
Friberg S., Mattson S. On the growth rates of human malignant tumors: implications for medical decision making // J. Surg. Oncol. 1997; 65: 284–297.
Garssen B. Psychological factors and cancer development: evidence after 30 years of research // Clin. Psychol. Rev. 2004; 24: 315–338.
Green A. I., Austen C. P. Psychopathology of pancreatic cancer. A psychobiologic probe // Psychosomatics. 1993; 34: 208–221.
Gross A. L., Gallo J. J., Eaton W. W. Depression and cancer risk: 24 years of follow-up of the Baltimore Epidemiologic Catchment Area sample // Cancer Causes Control. 2010; 21: 191–199.
Hahn R. C., Petitti D. B. Minnesota Multiphasic Personality Inventory-rated depression and the incidence of breast cancer // Cancer. 1988; 61 (4): 845–848.
Huang T., Poole E. M., Okereke O. I. et al. Depression and risk of epithelial ovarian cancer: Results from two large prospective cohort studies // Gynecol. Oncol. 2015; 139 (3): 481–486.
Inagaki M., Yoshikawa E., Kobayakawa M. et al. Regional cerebral glucose metabolism in patients with secondary depressive episodes after fatal pancreatic cancer diagnosis // J. Affect Disord. 2007; 99: 231–236.
Jacobs J. R., Bovasso G. B. Early and chronic stress and their relation to breast cancer // Psychol. Med. 2000; 30: 669–678.
Jemal A., Bray F., Center M. M. et al. Global cancer statistics // CA Cancer J. Clin. 2011; 61 (2): 69–90.
Kim-Fuchs C., Le C. P., Pimentel M. A. et al. Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment // Brain Behav. Immun. 2014; 40: 40–47.
Kroenke C. H., Bennett G. G., Fuchs C. et al. Depressive symptoms and prospective incidence of colorectal cancer in women // Am. J. Epidemiol. 2005; 162: 839–848.
Lemogne C., Consoli S. M., Melchior M. et al. Depression and the Risk of Cancer: A 15-year Follow-up Study of the GAZEL Cohort // Am. J. Epidemiol. 2013; 178 (12): 1712–1720.
Leong A. S. Y., Siavotinek A. H., Deakin E. J. The pathology of experimental chronic fibrosing pancreatitis: light microscopic and ultrastructural observations // Pathology. 1982; 14: 363–368.
Li R., Hou J., Xu Q. et al. High level interleukin-6 in the medium of human pancreatic cancer cell culture suppresses production of neurotransmitters by PC 12 cell line // Metab. Brain Dis. 2012; 27: 91–100.
Liebowitz M. R., Gorman J. M., Fyer A. J. et al. Lactate provocation of panic attacks: II. Biochemical and physiological findings // Arch. Gen. Psychiatry. 1985; 42: 709–719.
Malhi G. S., Byrow Y., Fritz K. et al. Mood disorders: neurocognitive models // Bipolar Disord. 2015; 17 (2): 3–20.
McGee R., Williams S., Elwood M. Depression and the development of cancer: a meta-analysis // Soc. Sci. Med. 1994; 38: 187–192.
McKenna M. C., Zevon M. A., Corn B. et al. Psychosocial factors and the development of breast cancer: a meta-analysis // Health Psychol. 1999; 18: 520–531.
Miao J. W., Liu L. J., Huang J. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma // Int. J. Oncol. 2014; 45: 165–176.
Oerleman M. E., Van den Akker M., Schuurman A. G. et al. A meta-analysis on depression and subsequent cancer risk // Clin. Pract. Epidemiol. Mental Health. 2007; 3: 29.
Ostuzzi G., Matcham F., Dauchy S. et al. Antidepressants for the treatment of depression in people with cancer // Cochrane Database Syst. Rev. 2018; 4 (4): CD011006.
Peery A. F., Dellon E. S., Lund J. et al. Burden of Gastrointestinal Disease in the United States: 2012 Update // Gastroenterology. 2012; 143 (5): 1179–1187.
Penninx B. W., Guralnik J. M., Pahor M. et al. Chronically depressed mood and cancer risk in older persons // J. Natl. Cancer Inst. 1998; 90: 1888–1893.
Pinquart M., Duberstein P. R. Depression and cancer mortality: a meta-analysis // Psychol. Med. 2010; 40: 1797–810.
Possel P., Adams E., Valentine J. C. Depression as a risk factor for breast cancer: investigating methodological limitations in the literature // Cancer Causes Control. 2012; 23: 1223–1229.
Satin J. R., Linden W., Phillips M. J. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis // Cancer. 2009; 115: 5349–5361.
Scarborough B. M., Smith C. B. Optimal pain management for patients with cancer in the modern era // CA Cancer J. Clin. 2018; 68 (3): 182–196.
Schuller H. M., Al-Wadei H. A., Ullah M. F. et al. Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention // Carcinogenesis. 2012; 33: 191–196.
Shan T., Ma J., Ma Q. et al. β2-AR-HIF-1α: a novel regulatory axis for stress-induced pancreatic tumor growth and angiogenesis // Curr. Mol. Med. 2013; 13: 1023–1034.
Sharma R. P., Tun N., Grayson D. R. Depolarization induces downregulation of DNMT1 and DNMT3a in primary cortical cultures // Epigenetics. 2008; 3: 74–80.
Siegel R. L., Miller K. D., Jemal A. Cancer statistics, 2016 // CA Cancer J. Clin. 2016; 66 (1): 7–30.
Spiegel D., Giese-Davis J. Depression and cancer: mechanisms and disease progression // Biol. Psychiatry. 2003; 54: 269–282.
Tilg H., Dinarello C. A., Mier J. W. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators // Immunol. Today. 1997; 18: 428–432.
Valkanova V., Ebmeier K. P., Allan C. L. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies // J. Affect Disord. 2013; 150: 736–744.
Vodermaier A., Linden W., Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments // J. Natl. Cancer Inst. 2009; 101 (21): 1464–88.
Watson M., Haviland J. S., Greer S. et al. Influence of psychological response on survival in breast cancer: a population-based cohort study // Lancet. 1999; 354: 1331–1336.
World Cancer Research Fund. https://www.wcrf.org/cancer-trends/global-cancer-data-by-country (date of access 26.06.2022).
Zhang T., Tan X. L, Xu Y. et al. Expression and prognostic value of indoleamine 2, 3-dioxygenase in pancreatic cancer // Chin. Med. J. (Engl). 2017; 130: 710–716.

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница